Revenue Breakdown
Composition ()
No data
Revenue Streams
Outset Medical Inc (OM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 41.5% of total sales, equivalent to $12.22M. Other significant revenue streams include Services and other revenue and Consoles. Understanding this composition is critical for investors evaluating how OM navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Outset Medical Inc maintains a gross margin of 39.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -53.73%, while the net margin is -60.61%. These profitability ratios, combined with a Return on Equity (ROE) of -94.23%, provide a clear picture of how effectively OM converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, OM competes directly with industry leaders such as ARAY and XTNT. With a market capitalization of $93.85M, it holds a leading position in the sector. When comparing efficiency, OM's gross margin of 39.38% stands against ARAY's 28.34% and XTNT's 66.13%. Such benchmarking helps identify whether Outset Medical Inc is trading at a premium or discount relative to its financial performance.
